Article

Sybodies targeting the SARS-CoV-2 receptor-binding domain

2020-04-18

Abstract excerpt

The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has resulted in a global health and economic crisis of unprecedented scale. The high transmissibility of SARS-CoV-2, combined with a lack of population immunity and prevalence of severe clinical outcomes, urges the rapid development of effective therapeutic countermeasures. Here, we report the generation of synthetic nanobodies, known as sybodies,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a5e3ce2c-5ea4-5401-9268-8a05ce9313c1
DOI: 10.1101/2020.04.16.045419

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Sybodies targeting the SARS-CoV-2 receptor-binding domainDOI 10.1101/2020.04.16.045419Read

Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2Semantic proximity Read

Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2Semantic proximity Read

A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drugSemantic proximity Read

A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2Semantic proximity Read

Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escapeSemantic proximity Read

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity NanobodySemantic proximity Read

A potent neutralizing nanobody against SARS-CoV-2 with inhaled delivery potentialSemantic proximity Read

Development of Potent and Effective Synthetic SARS-CoV-2 Neutralizing NanobodiesSemantic proximity Read

A potent synthetic nanobody targets RBD and protects mice from SARS-CoV-2 infectionSemantic proximity Read

Biparatopic sybody constructs neutralize SARS-CoV-2 variants of concern and mitigate emergence of drug resistanceSemantic proximity Read

Biparatopic sybodies neutralize SARS‐CoV‐2 variants of concern and mitigate drug resistanceSemantic proximity Read

Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2Semantic proximity Read